Nava Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 7

Nava Therapeutics General Information

Description

Operator of a biotechnology company intended to develop next-generation RNA therapeutics by creating advanced lipid nanoparticle delivery technology. The company's proprietary platform is designed to overcome challenges in RNA medicine, allowing targeted and safe delivery to be administered at clinically relevant doses while minimizing off-target effects, enabling healthcare industry to expand the potential of RNA-based treatments for serious diseases.

Contact Information

Website
www.navatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 600/700 One Kendall Square
  • Suite B
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 600/700 One Kendall Square
  • Suite B
  • Cambridge, MA 02139
  • United States

Nava Therapeutics Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nava Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 16-Jul-2026 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Jan-2024 Completed Pre-Clinical Trials
1. Seed Round $10M $10M Completed Pre-Clinical Trials
To view Nava Therapeutics’s complete valuation and funding history, request access »

Nava Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Nava Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nava Therapeutics Patents

Nava Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026207228-A2 Novel lipids, lipid compositions containing thereof, and methods of using thereof Pending 27-Mar-2025
WO-2025217298-A1 Novel lipids containing diketopiperazine core, lipid nanoparticle containing thereof, and methods of using thereof Pending 10-Apr-2024
WO-2025217299-A1 Novel lipids containing diketopiperazine core, lipid nanoparticle containing thereof, and methods of using thereof Pending 10-Apr-2024 C07D241/08

Nava Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nava Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Andreessen Horowitz Venture Capital Minority
F-Prime Venture Capital Minority
GV Corporate Venture Capital Minority
Readout Capital Hedge Fund Minority
You’re viewing 5 of 7 investors. Get the full list »

Nava Therapeutics FAQs

  • When was Nava Therapeutics founded?

    Nava Therapeutics was founded in 2022.

  • Where is Nava Therapeutics headquartered?

    Nava Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Nava Therapeutics?

    Nava Therapeutics has 37 total employees.

  • What industry is Nava Therapeutics in?

    Nava Therapeutics’s primary industry is Drug Discovery.

  • Is Nava Therapeutics a private or public company?

    Nava Therapeutics is a Private company.

  • What is Nava Therapeutics’s current revenue?

    The current revenue for Nava Therapeutics is .

  • How much funding has Nava Therapeutics raised over time?

    Nava Therapeutics has raised $89M.

  • Who are Nava Therapeutics’s investors?

    Alexandria Venture Investments, Andreessen Horowitz, F-Prime, GV, and Readout Capital are 5 of 7 investors who have invested in Nava Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process